Evosep: Funding, Investors & Team (Sep 2026)
Evosep creates fresh approaches to make clinical proteomics 10 times quicker and 100 times more reliable. We have a highly ambitious business plan to bring the community closer to the clinic, and we are aiming to meet the growing need for throughput with solid solutions for clinical and large-scale proteomics. We are critically considering the necessary system topologies for effective sample separation prior to mass spectrometric analysis and basing our design on years of expertise with nano-UHPLC R&D and application assistance.
Evosep has raised $40.0M across 1 funding round on record, the most recent an undisclosed round of $40.0M announced in Jan 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Evosep Company Profile and Key Stats
Latest funding round on record: Jan 2023.
Evosep Funding Rounds
Evosep Founders and Leadership Team
No contact details are on record for this team yet.
Evosep Funding Compared to Other Biotechnology Startups
Evosep's latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Evosep in Biotechnology and Odense
Companies Similar to Evosep
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
Evosep Funding FAQs
What does Evosep do?
Evosep creates fresh approaches to make clinical proteomics 10 times quicker and 100 times more reliable. We have a highly ambitious business plan to bring the community closer to the clinic, and we are aiming to meet the growing need for throughput with solid solutions for clinical and large-scale proteomics. We are critically considering the necessary system topologies for effective sample separation prior to mass spectrometric analysis and basing our design on years of expertise with nano-UHPLC R&D and application assistance.
How much funding has Evosep raised?
Evosep has raised $40.0M across 1 round on record. The most recent is an undisclosed round of $40.0M announced in Jan 2023.
When did Evosep last raise funding?
Evosep's most recent funding round on record is an undisclosed round of $40.0M, announced in Jan 2023.
Who founded Evosep?
FundedIQ lists Ole Vorm (Founder) at Evosep.
Where is Evosep headquartered?
Evosep is based in Odense, Syddanmark, Denmark.
How many employees does Evosep have?
Evosep is in the 11-50 employee band.
How does Evosep's funding compare to other Biotechnology startups?
Evosep's latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Evosep Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evosep is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.